TERENCE MAKOID: Open Payments
NPI 1194175505 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 23 payments from 12 companies in 2025. Trend: 2023 $282 · 2024 $418 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $128 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $101 |
| ABIOMED | 1 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Amgen Inc. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Novo Nordisk Inc | 2 | $53 |
| BridgeBio Pharma, Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Esperion Therapeutics, Inc. | 1 | $20 |
Products named: AMVUTTRA, LifeVest, LEQVIO, REPATHA, JARDIANCE, Wegovy, Attruby, CAMZYOS.
Industry payments across NC — which companies pay providers there.
